These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 31827061)
1. Transmembrane and Ubiquitin-Like Domain Containing 1 Protein (TMUB1) Negatively Regulates Hepatocellular Carcinoma Proliferation via Regulating Signal Transducer and Activator of Transcription 1 (STAT1). Chen Y; Fu H; Zhang Y; Chen P Med Sci Monit; 2019 Dec; 25():9471-9482. PubMed ID: 31827061 [TBL] [Abstract][Full Text] [Related]
2. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma. Huang D; Cao L; Zheng S J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067 [TBL] [Abstract][Full Text] [Related]
3. Oncogene Delta/Notch-Like EGF-Related Receptor Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma and Predicts a Poor Prognosis. Liang Y; Luo H; Zhang H; Dong Y; Bao Y Cancer Biother Radiopharm; 2018 Nov; 33(9):380-386. PubMed ID: 30235011 [TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway. Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171 [TBL] [Abstract][Full Text] [Related]
5. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A. Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761 [TBL] [Abstract][Full Text] [Related]
6. Tmub1 Suppresses Hepatocellular Carcinoma by Promoting the Ubiquitination of ΔNp63 Isoforms. Fu H; Zhang Y; Chen J; Zhou B; Chen G; Chen P Mol Ther Oncolytics; 2020 Sep; 18():126-136. PubMed ID: 32671188 [TBL] [Abstract][Full Text] [Related]
7. STAT1 negatively regulates hepatocellular carcinoma cell proliferation. Chen G; Wang H; Xie S; Ma J; Wang G Oncol Rep; 2013 Jun; 29(6):2303-10. PubMed ID: 23588992 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
9. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
10. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells]. Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma. Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401 [TBL] [Abstract][Full Text] [Related]
12. MiR-486-5p Suppresses Proliferation and Migration of Hepatocellular Carcinoma Cells through Downregulation of the E3 Ubiquitin Ligase CBL. He J; Xiao B; Li X; He Y; Li L; Sun Z Biomed Res Int; 2019; 2019():2732057. PubMed ID: 31976317 [TBL] [Abstract][Full Text] [Related]
13. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma. Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma. Zhou J; Li W; Guo J; Li G; Chen F; Zhou J Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956 [TBL] [Abstract][Full Text] [Related]
15. SOX18 Affects Cell Viability, Migration, Invasiveness, and Apoptosis in Hepatocellular Carcinoma (HCC) Cells by Participating in Epithelial-to-Mesenchymal Transition (EMT) Progression and Adenosine Monophosphate Activated Protein Kinase (AMPK)/Mammalian Target of Rapamycin (mTOR). Sun Y; Lei B; Huang Q Med Sci Monit; 2019 Aug; 25():6244-6254. PubMed ID: 31427562 [TBL] [Abstract][Full Text] [Related]
16. LncRNA AIRN influences the proliferation and apoptosis of hepatocellular carcinoma cells by regulating STAT1 ubiquitination. Cai H; Zheng Y; Wen Z; Yang Y; Yang S; Zhang Q Arch Pharm Res; 2021 Apr; 44(4):414-426. PubMed ID: 33759138 [TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma. Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of eEF1A1 regulates G1-phase progression to promote HCC proliferation through the STAT1-cyclin D1 pathway. Huang J; Zheng C; Shao J; Chen L; Liu X; Shao J Biochem Biophys Res Commun; 2017 Dec; 494(3-4):542-549. PubMed ID: 29079187 [TBL] [Abstract][Full Text] [Related]
19. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression. Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215 [TBL] [Abstract][Full Text] [Related]
20. [miR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression]. Wang J; Liu Z; Dou C; Han S; Li C; Tu K; Yang W Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):512-7. PubMed ID: 27053618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]